Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Times Interest Earned (2016 - 2025)

Ligand Pharmaceuticals' Times Interest Earned history spans 16 years, with the latest figure at $7.76 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 171.38% year-over-year to $7.76; the TTM value through Dec 2025 reached $8.7, up 216.83%, while the annual FY2025 figure was $8.7, 216.83% up from the prior year.
  • Times Interest Earned for Q4 2025 was $7.76 at Ligand Pharmaceuticals, down from $60.36 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $3078.0 in Q3 2023 and bottomed at -$41.77 in Q1 2025.
  • The 5-year median for Times Interest Earned is $7.54 (2025), against an average of $163.51.
  • The largest annual shift saw Times Interest Earned skyrocketed 8180.5% in 2023 before it crashed 297.12% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at $8.44 in 2021, then skyrocketed by 501.0% to $50.73 in 2022, then tumbled by 150.53% to -$25.63 in 2023, then soared by 57.62% to -$10.86 in 2024, then skyrocketed by 171.38% to $7.76 in 2025.
  • Per Business Quant, the three most recent readings for LGND's Times Interest Earned are $7.76 (Q4 2025), $60.36 (Q3 2025), and $7.32 (Q2 2025).